PPARG and diabetic cardiomyopathy: MiR-200b-3p has been reported to activate the PPAR-γ signalling pathway in diabetic cardiomyopathy [79], and its overexpression can decrease the expression levels of PPAR-γ in 3 T3-L1 cells [80].